Medi-Caps Limited

Company Profile

Medi-Caps Limited had its IPO on under the ticker symbol 523144.

The company operates in the Other sector and Other industry. Medi-Caps Limited has a staff strength of 0 employees.

Stock update

Shares of Medi-Caps Limited opened at ₹37.62 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹36.5 - ₹38.88, and closed at ₹36.91.

This is a -3.2% slip from the previous day's closing price.

A total volume of 10,109 shares were traded at the close of the day’s session.

In the last one week, shares of Medi-Caps Limited have slipped by -0.67%.

Medi-Caps Limited's Key Ratios

Medi-Caps Limited has a market cap of ₹279.95 million, indicating a price to book ratio of 0.2958 and a price to sales ratio of 0.6987.

In the last 12-months Medi-Caps Limited’s revenue was ₹422.48 million with a gross profit of ₹177.78 million and an EBITDA of ₹15.41 million. The EBITDA ratio measures Medi-Caps Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Medi-Caps Limited’s operating margin was -9.72% while its return on assets stood at -0.18% with a return of equity of 0%.

In Q3, Medi-Caps Limited’s quarterly earnings growth was a positive 0% while revenue growth was a negative 20.9%.

Medi-Caps Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

29.3453

PEG

Its diluted EPS in the last 12-months stands at ₹-4.826 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Medi-Caps Limited’s profitability.

Medi-Caps Limited stock is trading at a EV to sales ratio of 0.0458 and a EV to EBITDA ratio of 0.601. Its price to sales ratio in the trailing 12-months stood at 0.6987.

Medi-Caps Limited stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹1.26 billion

Total Liabilities

₹63.87 million

Operating Cash Flow

₹-25602000.00

Capital Expenditure

₹11.63 million

Dividend Payout Ratio

0%

Medi-Caps Limited ended 2024 with ₹1.26 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.26 billion while shareholder equity stood at ₹1.19 billion.

Medi-Caps Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹63.87 million in other current liabilities, 124700000.00 in common stock, ₹1.06 billion in retained earnings and ₹281.42 million in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹267.01 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

Medi-Caps Limited’s total current assets stands at ₹602.05 million while long-term investments were ₹0 and short-term investments were ₹255.87 million. Its net receivables were ₹84.64 million compared to accounts payable of ₹0 and inventory worth ₹70.69 million.

In 2024, Medi-Caps Limited's operating cash flow was ₹-25602000.00 while its capital expenditure stood at ₹11.63 million.

Comparatively, Medi-Caps Limited paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹36.91

52-Week High

₹53

52-Week Low

₹30.62

Analyst Target Price

₹

Medi-Caps Limited stock is currently trading at ₹36.91 per share. It touched a 52-week high of ₹53 and a 52-week low of ₹53. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹38.73 and 200-day moving average was ₹39.87 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6085.9% of the company’s stock are held by insiders while 0% are held by institutions.